ACTIVE SESSION TAPE Biotechnology $57M Cap Quant: HOLD

Why Is INmune Bio Inc. (INMB) Stock Down Today?

Updated Nov 19, 2026 6:53 PM ET · Prev Close $1.03

Pro Workspace
Last Session Price
$0.89 -13.19%
-$0.14 vs $1.03 prior close
Intraday Range
$0.89 – $1.03
Open $1.03
Relative Volume
1.17x Avg
411,626 sh
52-Week Range
$0.89 – $2.60
Benchmark Alpha
-11.23% vs SPY
-11.00% vs QQQ
20-Session Trend -38.8%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

INmune Bio Inc. Pulling Back 13.19% on 1.17x Relative Volume

INmune Bio Inc. (INMB) is pulling back 13.19% (-$0.14) to $0.89 on 1.17x average session volume. Relative to benchmarks, INMB is lagging the S&P 500 by -11.23%. 14-day RSI stands at 23.4, keeping momentum in a oversold regime.

NEWS 70% Weight
INmune Bio Inmb Q3 2026 Earnings Call Transcript

Management outlined a revised UK submission strategy and early named patient access plans for Ebstracel.

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.89) trades relative to 20-day SMA ($1.23) and 50-day SMA ($1.64).

Volume Confirmation
MODERATE VOLUME (1.17x) Normal
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

INMB lagging the S&P 500 by -11.23%
INMB Session
-13.19%
$0.89
S&P 500 (SPY)
-1.96%
$715.87
Nasdaq 100 (QQQ)
-2.19%
$645.04
Healthcare (XLV)
-2.05%
$177.46
Alpha vs SPY: -11.23% Alpha vs QQQ: -11.00% Alpha vs XLV: -11.14%

Options Flow & Execution Desk

TRADESTIE PRO DESK

Unlock 1 Strike-Verified Options Setup for INMB

Our options desk modeled ATM Call Rebound / Continuation structures for the Dec 18 expiration cycle, plus live unusual contract strike sweeps and full factor sub-scores.

Recent INMB Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.84
Short-term support band
Upper Bound
$0.94
Short-term resistance band
Key Inflection Level
$0.89 (session support)

Monitor volume expansion above 1.5x RVOL around $0.89 (session support) for directional breakout confirmation.

Technical Regime (INMB)

BEARISH MA TREND
RSI (14)
23.4
Oversold
20-Day SMA
$1.23
Below 20d
50-Day SMA
$1.64
Below 50d
MACD Signal
Bearish
MACD -0.20
ADX (14)
42.7
Strong trend
10d Momentum
-0.28
Soft 10-day momentum

Retail & Crowd Sentiment

Bullish
24h Messages
0
7d avg 0.4
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Bearish sentiment dominates $INMB on StockTwits with no positive news to offset the negative sentiment.

Reddit communities: 1 comment (Bullish)

About INmune Bio Inc.

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, Xpro1595, LIVNate, and others.

Sector
Healthcare
Market Cap
$57M
Employees
13

Get Instant INMB Catalyst Alerts

Receive an email alert when INMB triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

INMB Session & Catalyst FAQ

Why is INMB stock down today?

INmune Bio Inc. (INMB) is pulling back 13.19% (-$0.14) to $0.89 on 1.17x average session volume. Relative to benchmarks, INMB is lagging the S&P 500 by -11.23%. 14-day RSI stands at 23.4, keeping momentum in a oversold regime.

Is INMB stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 1.17x relative volume (moderate participation). Our multi-factor model currently rates INMB as HOLD. Review full valuation, quality, and timing signals on the INMB Buy or Sell Decision Brief →

What is INMB's intrinsic value and expected trading range?

At $0.89, INMB's modeled 1-to-3 session range is $0.84 – $0.94, with a key inflection level at $0.89 (session support). Compare current price against multi-year cash flow projections in the INMB Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for INMB?

RSI at 23.4 indicates oversold conditions — watch for mean-reversion support. INMB trades at $0.89 relative to its 20-day SMA ($1.23) and 50-day SMA ($1.64), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs